ANTIBODIES IN THE SERUM OF PATIENTS WITH AUTOIMMUNE THYROID-DISORDERS REACT WITH A RECOMBINANT-98 AMINO-ACID FRAGMENT OF A FULL LENGTH 64 KDA EYE MUSCLE MEMBRANE-PROTEIN WHICH IS ALSO EXPRESSED IN THE THYROID

被引：16

作者：

ZHANG, ZG ^{[1
]}

DONG, Q ^{[1
]}

RODIEN, P ^{[1
]}

ALCALDE, L ^{[1
]}

BERNARD, N ^{[1
]}

BOUCHER, A ^{[1
]}

SALVI, M ^{[1
]}

ARTHURS, B ^{[1
]}

VASSART, GM ^{[1
]}

LUDGATE, M ^{[1
]}

WALL, JR ^{[1
]}

机构：

[1] MONTREAL GEN HOSP,CTR THYROID STUDIES,MONTREAL H3G 1A4,QUEBEC,CANADA

来源：

AUTOIMMUNITY | 1992年 / 13卷 / 02期

基金：

美国国家卫生研究院; 英国医学研究理事会;

关键词：

THYROID-ASSOCIATED OPHTHALMOPATHY; 64 KDA ANTIGEN; THYROID AUTOIMMUNITY; DOT BLOT ASSAY; WESTERN BLOTTING;

D O I：

10.3109/08916939209001916

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We have tested sera from patients with autoimmune thyroid disorders with or without ophthalmopathy for immunoreactivity, in a dot blot assay, against a recombinant 98 amino acid fragment of a cloned 64 kDa protein, D1, which is expressed in human eye muscle and thyroid, in the form of a Lac Z fusion protein. Tests were positive in 19 out of 40 patients with established thyroid-associated ophthalmopathy (TAO), in 12 out of 21 patients with Graves' hyperthyroidism (GH) without clinically evident ophthalmopathy, in 5 out of 10 patients with thyroid autoimmunity and lid retraction but no other signs of ophthalmopathy, in 4 out of 23 patients with Hashimoto's thyroiditis (HT) without evident ophthalmopathy and in 2 out of 18 patients with benign adenoma or multinodular goitre, but in only 2 out of 37 normal subjects tested. SDS-polyacrylamide gel electrophoresis and Western blotting for an antibody reactive with a 64 kDa antigen in pig eye muscle membranes was also carried out on sera from patients with TAO and GH. While immunoblotting for antibodies reactive with a 64 kDa protein was more often positive in patients with TAO, in whom 58% had serum antibodies which reacted with a 64 kDa protein, this was not the case in patients with GH without eye signs in whom the prevalence of positive immunoblot tests was 35%. Overall there was a fairly close correlation between the two tests although there were many exceptions. While the apparent discrepancy between antibodies recognizing the human recombinant 98 amino acid peptide in dot blot and those binding to a 64 kDa protein in pig eye muscle membranes in immunoblot could be explained by the existence of more than one epitope on the native protein, it is possible that the peptide D1 and the 64 kDa molecule are different. Although the relationship of these antibodies to the ophthalmopathy is uncertain, the high prevalences of antibodies to the D1 fusion protein in patients with GH without evident ophthalmopathy (but who may have subclinical disease) and in patients with thyroid autoimmunity with lid retraction, which many believe to be an early stage of ophthalmopathy, raises the possibility that these antibodies may be an early marker of the eye disease in patients with thyroid autoimmunity. Further molecular studies will show whether D1 and the 64 kDa protein are the same or different molecules while prospective clinical studies of these patient groups will be necessary to determine the significance of the corresponding antibodies.

引用

页码：151 / 157

页数：7

共 26 条

[11]

Mengistu M., Laryea E.A., Miller A., Wall J.R., Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence, Clin Exp Immunol, 65, pp. 19-27, (1986)

[12]

Wang P.W., Hiromatsu Y., Laryea E.A., How J.R., Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy, J Clin Endocrinol Metαb, 63, pp. 316-320, (1986)

[13]

Hiromatsu Y., Fukazawa H., How J., Wall J.R., Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy—roles of Class II MHC antigen expression and interferon-γ action on effector and target cells, Clin Exp Immunol, 70, pp. 593-603, (1987)

[14]

Hiromatsu Y., How J., Fukazawa H., Guinard Salvi F.M., How J., Wall J.R., A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy, J Clin Endocrinol Metαb, 67, pp. 565-570, (1988)

[15]

Hiromastu Y., Cadarso L., Salvi M., Wall J.R., Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy, Autoimmunity, 5, pp. 205-213, (1990)

[16]

Hiromatsu Y., Wang P.W., Wosu L., How J., Wall J.R., Mechanisms of immune damage in Graves' ophthalmopathy, Hor Res, 26, pp. 198-207, (1987)

[17]

Salvi M., Bernard N., Miller A., Zhang Z.-G., Gardini A., Wall J.R., Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy, Thyroid, 1, pp. 207-213, (1991)

[18]

Elisei R., Dong Q., Weightman D., Ludgate M., Cloning and sequencing of candidate eye muscle antigens in Graves' ophthalmopathy, (1991)

[19]

Dong Q., Ludgate M., Vassart G., Novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease, J Clin Endocrinol Metab, 72, pp. 1375-1381, (1991)

[20]

Laemmli U.K., Cleavage of structural proteins during assembly of the head of bacteriophage T4, Nature, 227, pp. 680-684, (1970)

← 1 2 3 →